Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

In sum, the mid-October “crypto Black Friday” crash has ignited a firestorm of questions about market manipulation and the fragility of trading infrastructure. Evidence of suspicious whale trades, exchange glitches, and perfectly-timed exploits suggest that the rout may have been at least partly orchestrated, rather than a natural response to bad news. Regulators are under pressure to scrutinize what really happened behind the scenes. The crypto market, meanwhile, is gingerly finding its footing again. Bitcoin’s price is well off its highs but signs of resilience – from hodlers doubling down to institutional money staying put – offer hope that the
17 October 2025
XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

XORTX Stock Price Skyrockets on Acquisition News Shares of XORTX Therapeutics Inc. (NASDAQ: XRTX) surged on October 17, 2025 after the nano-cap biotech announced a strategic acquisition in its core therapeutic area. The stock rocketed up immediately following the morning press release, spiking up to 40% in early trading. By midday, XRTX was changing hands at just over $1.20 per share (up from around $0.86 the prior day)ragingbull.com. It eventually closed about 21% higher on Fridaytipranks.com – a dramatic move for a company that had been trading quietly near the $1 level. This rally was accompanied by an explosion in
17 October 2025
Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

FDA Setback Triggers Strategic Review Kezar Life Sciences revealed a major regulatory setback for its lead drug and immediately pivoted to consider strategic alternatives. In an October 16 press release, the South San Francisco company announced it failed to reach alignment with the U.S. Food and Drug Administration on the design of a pivotal trial for zetomipzomib in autoimmune hepatitis (AIH)ca.investing.com. The FDA abruptly canceled a Type C meeting that was scheduled for Q4 2025 to discuss Kezar’s proposed Phase 3 trial, and instead requested a new standalone study to characterize zetomipzomib’s pharmacokinetics in patients with severe liver impairmentstocktitan.netstocktitan.net. The
17 October 2025
Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

FDA Voucher Ignites IRON Stock Rally Disc Medicine’s stock price (NASDAQ: IRON) spiked dramatically in mid-October 2025 after news of the FDA voucher, vaulting from the mid-$70s to the low-$90s in a single daygurufocus.com. On Friday (Oct. 17), IRON opened around $85 and surged to an intraday high of $92.50 before closing at $93.00, marking a ~25% jump on the daystockanalysis.com. This leap capped a steady uptrend over the past month – the shares were trading near $60 in early September and gradually climbed into the $70s as anticipation built around bitopertin’s NDA filing and reviewstockanalysis.comstockanalysis.com. The FDA’s award of
17 October 2025
Nebius (NBIS) Stock Rockets on $17B Microsoft AI Deal – Explosive Growth & Outlook Revealed

Nebius Group (NBIS) Skyrockets 350% on AI Deal, Then Stumbles – What’s Next for This Cloud Newcomer?

Nebius Stock’s Wild 2025 Ride – From $14 to $130+ 🚀 Nebius Group’s logo on display – the AI cloud upstart has seen its stock skyrocket in 2025 amid major deals. Few stocks captured the AI frenzy of 2025 like Nebius Group. This Amsterdam-headquartered cloud upstart – born from the breakup of Russia’s Yandex – has seen its Nasdaq-listed shares soar by triple digits. Year-to-date, NBIS has climbed roughly +350%, far outpacing broader tech indicests2.tech. The stock hit an all-time high around $132-$135 in early October, a stunning jump from just ~$14 a year agots2.tech. As one analysis noted, Nebius’
Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom

Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom

Menopause Launch Sparks Surge in HIMS Stock Hims & Hers’ expansion into menopause care was greeted with enthusiasm in the market. On October 15, the San Francisco–based telehealth provider announced it is now offering affordable treatment plans for women in perimenopause and menopause via its Hers platform businesswire.com businesswire.com. The move adds a new specialty to Hers, which already serves over 500,000 women subscribers businesswire.com. By connecting patients with providers trained in menopause care, Hims & Hers aims to fill a long-neglected gap in women’s health. “Women have been navigating an outdated healthcare system that wasn’t designed for them for
17 October 2025
Regions Financial Stock Surges on Strong Q3 Profit; Analysts Upbeat on Outlook

Regions Financial Stock Surges on Strong Q3 Profit; Analysts Upbeat on Outlook

Stock Price and Recent Performance Regions Financial’s stock has seen whipsaw volatility in recent days. Last week’s renewed banking sector fears – sparked by a $50 million fraud-related loan loss at Zions Bancorp and other credit worries – hit regional bank stocks hard, sending the KBW Regional Banking Index down over 6% on Oct. 16 ts2.tech. Regions was caught in that downdraft, with RF shares plunging about 5–6% on Thursday (Oct. 16) to close around $23.33 marketbeat.com, a multi-month low. However, sentiment swiftly reversed after Regions reported strong Q3 results before the market opened on Oct. 17. The stock bounced roughly 2% higher in
17 October 2025
VirnetX Stock Soars 71% on Major Government Contract – What’s Next for VHC?

VirnetX Stock Soars 71% on Major Government Contract – What’s Next for VHC?

Major Government Contract Sends VHC Soaring VirnetX shocked the market with an eye-popping rally on October 17, 2025, after unveiling a significant government deal. The Nevada-based cybersecurity firm announced it won a General Services Administration (GSA) Multiple Award Schedule contract late Thursday, and by Friday’s open the stock exploded upward stocktwits.com. Shares opened 71% higher and briefly touched a level not seen in over two years stocktwits.com. The exuberance was directly tied to the GSA news, which investors interpreted as a game-changer for VirnetX’s federal business prospects. The GSA Multiple Award Schedule is essentially a pre-approved vendor list and purchasing
17 October 2025
Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Bumpy Ride for CRM Stock in 2025 Salesforce’s stock (NYSE: CRM) has been on a rollercoaster in recent weeks. After a steep September sell-off – when cautious guidance sent shares to multi-month lows around $235ts2.tech – the stock found a footing in the mid-$230s. Heading into mid-October, CRM began to stabilize. On October 16, shares surged about 4% after Salesforce issued a surprisingly strong long-term forecast, lifting the stock to roughly $246 by Thursday’s closereuters.com. That rebound comes as a relief to investors: even after the pop, CRM remains down roughly 27–29% year-to-datereuters.com, a stark contrast to major indexes. In
J.B. Hunt (JBHT) Stock Soars on Earnings Surprise – Is a Freight Sector Revival Underway?

J.B. Hunt Stock Skyrockets 22% After Earnings Shock – Can the Rally Hold?

J.B. Hunt’s corporate headquarters in Lowell, Arkansas. The trucking giant delivered an earnings surprise that sent its stock soaring. Stock Rockets on Earnings Beat J.B. Hunt’s stock exploded higher after the company’s third-quarter results blew past expectations. Shares surged from about $139 (Wednesday’s close) to $169.57 by Thursday’s close, a 22.1% one-day leapfinviz.com. Investors haven’t seen a move like that in years – the best single-day gain in decades for J.B. Hunt’s stock, according to market watchers. The price spike came on unusually heavy trading volume (6.5 million shares traded vs. an average of ~1–2 million), reflecting intense interest from
17 October 2025
Harrison Global Stock Surges on Bitcoin Treasury Strategy and Expansion Plans

Harrison Global Stock Surges on Bitcoin Treasury Strategy and Expansion Plans

Harrison Global Holdings (NASDAQ: BLMZ) shares jumped about 11–12% on Oct 17, 2025, trading near $0.22 google.com (up from around $0.19 the previous session investing.com). A pre-market report noted a ~19% spike to $0.23 after hours gurufocus.com. – The company announced on Oct 17 a binding term sheet with White Lion Capital to execute a Bitcoin Purchase Agreement, formally launching a “Bitcoin Treasury Strategy” marketwirenews.com. Harrison says this is meant to diversify its cash reserves and hedge inflation marketwirenews.com. – Investor Sentiment: Technical indicators are mixed. GuruFocus notes BLMZ’s RSI is around 47 (neutral) and its annualized volatility is very
17 October 2025
Newmont Stock Skyrockets as Gold Rally Hits Record Highs – Will the Boom Continue?

Newmont Stock Skyrockets on Gold Boom: Record Highs, $100 B Milestone & Bold Forecasts

Newmont Shares Soar to Multi-Year Highs Newmont’s stock price has been on a tear, skyrocketing this week to levels not seen in years. Shares traded around the high-$90s on October 17 – up sharply from the low-$80s just a week ago – after rallying ~14.8% from last Friday to Thursday’s close alonefinviz.com. The stock hit a fresh 52-week high near $98.58 on Thursdayfinviz.com, and in doing so Newmont’s market cap crossed the $100 billion threshold for the first timeboerse-am-sonntag.de. This milestone is significant: Newmont is now on the cusp of becoming the first-ever gold mining company valued in twelve digits, reflecting
17 October 2025
BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA Stock Soars on Failed Sabadell Takeover Bid – Analysts See Upside Ahead

BBVA Shares Jump as Takeover Bid Collapses Madrid, October 17, 2025 – Banco Bilbao Vizcaya Argentaria (BBVA) stock jumped sharply on Friday after the Spanish banking giant’s hostile bid for Banco Sabadell fell through. BBVA shares rose about 5–7% in Madrid trading, closing near €16.8 (up roughly 6.9% on the day)investing.comreuters.com, while Sabadell’s stock plunged over 6%reuters.com. The rally came as BBVA announced it would immediately restart share buybacks – buying back €1 billion of its own shares starting October 31 – now that the Sabadell deal is off the tablets2.tech. BBVA also declared its largest-ever interim dividend of €0.32 per
Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Stock Price Surge & Recent Performance Achieve Life Sciences stock exploded higher on the FDA news, reflecting growing optimism around cytisinicline’s prospects. In pre-market trading on Oct. 17, ACHV jumped about 22.7% after the company revealed it received a rare FDA Commissioner’s National Priority Voucher (CNPV) for cytisinicline’s vaping cessation indication investing.com. This rally propelled the shares to multi-month highs in the mid-$3 range. Earlier in the week, ACHV had already begun gaining momentum – on Oct. 15 the stock broke above its 200-day moving average (~$2.81) and hit $3.19 marketbeat.com, a bullish technical signal. As of Thursday’s close (Oct.
Huntington Bancshares’ Profit Surge Defies Banking Jitters – HBAN Stock Eyes Rebound

Huntington Bancshares’ Profit Surge Defies Banking Jitters – HBAN Stock Eyes Rebound

HBAN Stock Bounces After Regional Bank Rout HBAN shares are attempting a comeback after a volatile week. On October 16, Huntington’s stock slid 5.2% to $15.37 markets.financialcontent.com amid a broader rout in regional bank stocks. Credit jitters hit the sector after a “cockroach” of bad loan news – one mid-sized lender disclosed a fraud-linked loss and another flagged sour commercial loans ts2.tech ts2.tech. The KBW Regional Bank Index plunged ~6.5% that day ts2.tech, dragging down even healthy banks like Huntington. However, Huntington’s strong earnings report on Friday, Oct. 17 helped ease those fears. The bank’s better-than-expected results and upbeat guidance
17 October 2025
Ally Financial Stock Soars on Profit Surge – Analysts Bullish on What’s Next

Ally Financial Stock Soars on Profit Surge – Analysts Bullish on What’s Next

Strong Q3 Earnings Fuel Rally Ally Financial delivered an upside surprise in Q3 2025, powering a relief rally in its stock. The Detroit-based digital bank – a major auto lender and online banking provider – reported third-quarter earnings on October 17 that handily beat expectations. Net income more than doubled year-over-year, rising to $371 million (GAAP EPS $1.18) versus $171 million (EPS $0.55) in Q3 2024 nasdaq.com. On an adjusted basis, earnings were $1.15 per share, about 14% above analyst consensus of ~$1.01 chartmill.com. Revenue came in at $2.17 billion, up ~3% from a year ago and slightly ahead of
17 October 2025
Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

RANI Stock Price Explodes on Deal News Rani Therapeutics’ stock price skyrocketed on Friday, Oct. 17, after the company unveiled a major partnership and funding news. In pre-market trade, RANI jumped about 150% and continued to rally after the market open tipranks.com. The stock, which had closed at just $0.47 the prior day, briefly hit approximately $1.37 per share – nearly a 3× gain in value google.com. By midday, shares were still trading around the $1.30 level, up almost +180% on the day. This stunning one-day move snapped RANI out of penny-stock territory and back above the Nasdaq’s $1 minimum
17 October 2025
Fifth Third’s Stock Jumps on Earnings Beat and Mega-Merger – Is FITB a Buy Now?

Fifth Third’s Stock Jumps on Earnings Beat and Mega-Merger – Is FITB a Buy Now?

Fifth Third Stock Rallies After Turbulent Week Fifth Third Bank logo is seen in this illustration taken April 23, 2024 (REUTERS/Dado Ruvic). Fifth Third’s stock is bouncing back to end a volatile week. By midday Friday (Oct. 17), FITB shares were trading around $41–$42, up roughly 2–3% after the bank’s strong earnings report beat expectations reuters.com. The mini-rally follows a sharp selloff in regional bank stocks just one day earlier: on Thursday, Fifth Third fell about 4% as part of a broader rout fueled by credit worries ts2.tech. News of surprise loan losses at two peer banks – Zions and
SLB Stock Q3 Beat, $4B Buybacks & Oil Swoon: Will Schlumberger (SLB) Rebound?

SLB Stock Q3 Beat, $4B Buybacks & Oil Swoon: Will Schlumberger (SLB) Rebound?

Q3 Earnings Recap: Resilient Results Amid Oil Slowdown SLB’s third-quarter 2025 results, released on Oct 17, showed better-than-expected profitability even as industry conditions softened. The company earned $0.69 per share (adj.) for Q3, topping estimates of $0.66 Tipranks. Revenue came in at $8.93 billion, essentially on target Tipranks. Both metrics were down modestly from a year ago (EPS was $0.89, revenue $9.16 B in Q3 2024) as global drilling activity has cooled. CEO Olivier Le Peuch described the quarter as “resilient,” noting SLB expanded its EBITDA margins and generated $1.8 B in free cash flow, thanks to efficiency gains Investing Investing. North America
American Express Raises Forecasts Amid Spending Boom – Is AXP Stock Poised to Soar?

American Express Raises Forecasts Amid Spending Boom – Is AXP Stock Poised to Soar?

AXP Stock Near Highs on Earnings Momentum American Express shares have been on a tear in recent months. The stock surged roughly 50% off its April lows following market jitters over tariffs, ultimately reaching a record high of $349.19 earlier this month Schwabnetwork. After peaking, AXP saw a quick 9.5% pullback over 14 trading days to around $315, before buyers stepped in. Notably, a single-session jump of +3% on Tuesday, October 14 helped break the downtrend and lifted the stock back above its 21-day moving average near $329 Schwabnetwork. As of October 17, AXP hovers around the $330 level, putting

Stock Market Today

Data Center Stocks Surge Into the Weekend: Digital Realty, Equinix and Vertiv Set Up a Big Week Ahead

Data Center Stocks Surge Into the Weekend: Digital Realty, Equinix and Vertiv Set Up a Big Week Ahead

7 February 2026
Digital Realty, Equinix, and Vertiv shares surged Friday, with Vertiv up 10% and Digital Realty rising 4.1%, as investors rotated back into AI-linked data center stocks. The move followed Amazon’s $200 billion and Alphabet’s $175–185 billion 2026 capex targets. Digital Realty set 2026 core FFO guidance at $7.90 to $8.00 per share. Wall Street ended the week broadly higher, led by chipmakers.
Quantum computing stocks bounce hard: IonQ, Rigetti, D‑Wave rally as traders reset for a data-heavy week

Quantum computing stocks bounce hard: IonQ, Rigetti, D‑Wave rally as traders reset for a data-heavy week

7 February 2026
IonQ, Rigetti, D‑Wave, and Quantum Computing Inc shares surged 15–21 percent Friday, erasing losses from the previous session. The rebound followed a Wall Street rally that sent the Dow above 50,000 for the first time. IonQ remains under scrutiny after a short-seller report questioned its Pentagon contract revenue. Investors await delayed U.S. jobs and inflation data next week.
Defense and space stocks rally, but Trump’s buyback-dividend squeeze is the next test

Defense and space stocks rally, but Trump’s buyback-dividend squeeze is the next test

7 February 2026
U.S. space and defense stocks rose Friday, with sector ETFs gaining up to 4.8% and Lockheed Martin up 2.4%. Investors are awaiting a Pentagon list that could restrict buybacks and dividends at underperforming contractors under a Trump executive order. Companies named would have 15 days to submit remediation plans. Lockheed’s board approved a $3.45 per share dividend for Q1 2026.
Go toTop